Skip to main content
Year archive

Lee's Pharmaceutical Holdings Limited — 2023 filings

All 41 regulatory filings released by Lee's Pharmaceutical Holdings Limited (950) in 2023, sourced directly from the official regulator.

41 Filings
2023 Period
2023 filings (41)
Filing Released Lang
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
Voluntary Announcement - Adasuve Obtains Drug Registration Certificate
Regulatory Filings
2023-11-28 English
Discloseable Transaction - Disposal of Assets
Capital/Financing Update
2023-11-13 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Share Issue/Capital Change
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-03 English
Interm Report 2023
Interim / Quarterly Report H1 2023
2023-09-15 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
Interim Dividend for the Six Months Ended 30 June 2023
Notice of Dividend Amount
2023-08-30 English
Interim Results for the Six Months Ended 30 June 2023
Interim / Quarterly Report H1 2023
2023-08-30 English
Voluntary Announcement - Update on an Investigational Anesthesia Product
Regulatory Filings
2023-08-21 English
Voluntary Announcement - Apremilast Tablet Obtains Drug Registration Certificate
Regulatory Filings
2023-08-21 English
Profit Warning
Regulatory Filings
2023-08-21 English
Supplemental Announcement Regarding Annual Report for the Year Ended 31 December 2022
Regulatory Filings
2023-08-21 English
Notice of Board Meeting
Regulatory Filings
2023-08-18 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-07-31 English
Change of Auditor
Audit Report / Information FY 2023
2023-07-06 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Share Issue/Capital Change
2023-07-03 English
Voluntary Announcement - INOmax DSIR Plus Delivery System Obtains Medical Device Registration Certificate
Regulatory Filings
2023-06-09 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
Amended and Restated Memorandum and Articles of Association
Governance Information
2023-05-18 English
List of Directors and their Roles and Functions
Board/Management Information
2023-05-17 English
(1) Poll Result of Annual General Meeting held on 17 May 2023&#x3b; (2) Resignation of an Independent Non-executive Director&#x3b; (3) Appointment of an Independent Non-executive Director&#x3b; and (4
Declaration of Voting Results & Voting Rights Announcements
2023-05-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Share Issue/Capital Change
2023-05-02 English
Cessation of Quarterly Financial Results Publication
Regulatory Filings
2023-04-28 English
Proxy Form
Proxy Solicitation & Information Statement
2023-04-21 English
General Mandates to Repurchase Shares and to Issue New Shares, Re-election of Directors, Appointment of Independent Non-Executive Director, Adoption of Amended and Restated Memorandum and Articles of
AGM Information
2023-04-21 English
Notice of Annual General Meeting
AGM Information
2023-04-21 English
Environmental, Social and Governance Report 2022
Regulatory Filings
2023-04-21 English
Annual Report 2022
Annual Report FY 2022
2023-04-21 English
Proposed Appointment of Independent Non-Executive Director
Board/Management Information
2023-04-19 English
Proposed Adoption of Amended and Restated Memorandum and Articles of Association
Governance Information
2023-04-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Share Issue/Capital Change
2023-04-04 English
Final Dividend for the year ended 31 December 2022
Notice of Dividend Amount
2023-03-30 English
Announcement of Annual Results for the year ended 31 December 2022
Annual Report FY 2022
2023-03-30 English
Notice of Board Meeting
Regulatory Filings
2023-03-20 English
Profit Warning
Regulatory Filings
2023-03-20 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Share Issue/Capital Change
2023-03-02 English
Voluntary Announcement - Business Update on the Extended Phase 2b Study of Tafoxiparin by Dilafor
Capital/Financing Update
2023-02-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
Voluntary Announcement - Inclusion of Treprostinil Injection, Teglutik and Trittico in the National Reimbursement Drug List
Regulatory Filings
2023-01-19 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Share Issue/Capital Change
2023-01-03 English